Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment

Vince B C Biemans, C Janneke van der Woude, Gerard Dijkstra, Andrea E van der Meulen-de Jong, Mark Löwenberg, Nanne K de Boer, Bas Oldenburg, Nidhi Srivastava, Jeroen M Jansen, Alexander G L Bodelier, Rachel L West, Annemarie C de Vries, Jeoffrey J L Haans, Dirk de Jong, Frank Hoentjen, Marieke J Pierik,

Research output: Contribution to journal › Article › Academic › peer-review

7 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Ustekinumab is associated with superior effectiveness outcomes compared to vedolizumab in Crohn's disease patients with prior failure to anti-TNF treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences